Patents by Inventor Trudy Rachel Doe

Trudy Rachel Doe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030022822
    Abstract: SBSEMN1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing SBSEMN1 polypeptides and polynucleotides in therapy, and diagnostic assays for such.
    Type: Application
    Filed: March 15, 2001
    Publication date: January 30, 2003
    Inventors: David Michalovich, Trudy Rachel Doe, Philip David Hayes
  • Publication number: 20020082385
    Abstract: Tubby 2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Tubby 2 polypeptides and polynucleotides in the design of protocols for the treatment of diabetes, obesity, and atherosclerosis, among others, and diagnostic assays for such conditions.
    Type: Application
    Filed: January 4, 2001
    Publication date: June 27, 2002
    Inventors: Jonathan Alexander Terrett, Tania Tamson Testa, Israel Simon Gloger, Stephen A. Hughes, Trudy Rachel Doe
  • Publication number: 20010021702
    Abstract: CSB2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CSB2 polypeptides and polynucleotides in therapy, and diagnostic assays for such.
    Type: Application
    Filed: February 5, 2001
    Publication date: September 13, 2001
    Inventors: Thierry Paul Gerard Calmels, Michael Louis Souchet, Isabelle Marie Leger, Laurence Nathalie Patricia Tourtelier, Antoine Michel Alain Bril, Trudy Rachel Doe
  • Patent number: 6200776
    Abstract: The hNBC3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing hNBC3 polypeptides and polynucleotides in therapy, and diagnostic assays for such.
    Type: Grant
    Filed: July 15, 1998
    Date of Patent: March 13, 2001
    Assignees: Yale University School of Medicine, SmithKline Beecham Corporation P.L.C., SmithKline Beecham Laboratories Pharmaceutiques
    Inventors: Walter F Boron, Antoine Michel Alain Bril, Nassirah Khandoudi, Xavier Martin, Steven Charles Jupe, Christopher John Rawlings, Trudy Rachel Doe
  • Patent number: 6187908
    Abstract: Tubby 2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Tubby 2 polypeptides and polynucleotides in the design of protocols for the treatment of diabetes, obesity, and atherosclerosis, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: February 13, 2001
    Assignee: SmithKline Beecham, P.L.C.
    Inventors: Jonathan Alexander Terrett, Tania Tamson Testa, Israel Simon Gloger, Stephen A. Hughes, Trudy Rachel Doe